-
1
-
-
33947310234
-
-
Brunner-La Rocca HP, Kaiser C, Pfisterer M, behalf of the BASKET Investigators. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007;28:719-725.
-
Brunner-La Rocca HP, Kaiser C, Pfisterer M, behalf of the BASKET Investigators. Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 2007;28:719-725.
-
-
-
-
2
-
-
0141863201
-
E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS)
-
Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, Breithardt G; E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
-
(2003)
Lancet
, vol.362
, pp. 1093-1099
-
-
Schofer, J.1
Schluter, M.2
Gershlick, A.H.3
Wijns, W.4
Garcia, E.5
Schampaert, E.6
Breithardt, G.7
-
3
-
-
24644477492
-
Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial
-
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-1223.
-
(2005)
JAMA
, vol.294
, pp. 1215-1223
-
-
Stone, G.W.1
Ellis, S.G.2
Cannon, L.3
Mann, J.T.4
Greenberg, J.D.5
Spriggs, D.6
O'Shaughnessy, C.D.7
DeMaio, S.8
Hall, P.9
Popma, J.J.10
Koglin, J.11
Russell, M.E.12
TAXUS, V.13
-
4
-
-
28444479818
-
Should degenerated saphenous vein graft routinely be sealed with drug-eluting stents?
-
Vermeersch P, Agostoni P. Should degenerated saphenous vein graft routinely be sealed with drug-eluting stents? J Interven Cardiol 2005;18:467-473.
-
(2005)
J Interven Cardiol
, vol.18
, pp. 467-473
-
-
Vermeersch, P.1
Agostoni, P.2
-
5
-
-
33845410666
-
Randomized double-blind comparison of sirolimus eluting stent versus bare metal stent implantation in diseased saphenous vein grafts: 6-month angiographic, intravascular ultrasound and clinical follow up of the RRISC trial
-
Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G. Randomized double-blind comparison of sirolimus eluting stent versus bare metal stent implantation in diseased saphenous vein grafts: 6-month angiographic, intravascular ultrasound and clinical follow up of the RRISC trial. J Am Coll Cardiol 2006;48:2423-2431.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 2423-2431
-
-
Vermeersch, P.1
Agostoni, P.2
Verheye, S.3
Van den Heuvel, P.4
Convens, C.5
Bruining, N.6
Van den Branden, F.7
Van Langenhove, G.8
|